A New Immunohistochemistry Prognostic Score (IPS) for Recurrence and Survival in Pancreatic Neuroendocrine Tumors (PanNET)

被引:0
|
作者
Viudez, Antonio
Carvalho, Filipe L. F.
Maleki, Zahra
Zahurak, Marianna
Laheru, Daniel
Stark, Alejandro
Azad, Nilofer S.
Wolfgang, Christopher L.
Baylin, Stephen
Herman, James G.
De Jesus-Acosta, Ana
机构
[1] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
812
引用
收藏
页码:205A / 205A
页数:1
相关论文
共 50 条
  • [21] GETNE-SILVELUL study: A new immunohistochemical score (SPI) in patients (pts) with pancreatic neuroendocrine tumors (PanNET) treated with everolimus or captem.
    Viudez, Antonio
    Crespo, Guillermo
    Gomez-Dorronsoro, Maria Luisa
    Benavent, Marta
    Hernando, Jorge
    Goni, Saioa
    Garcia, Beatriz
    Sevilla, Isabel
    Alonso, Vicente
    Gonzalez-Borja, Iranzu
    Lopez, Carlos
    Custodio, Ana
    Hernandez, Irene
    Llanos, Marta
    Carmona, Alberto
    Perez-Sanz, Jairo
    San Vicente, Borja Lopez
    De Jesus-Acosta, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Cetinkaya, Raziye Boyar
    Vatn, Morten
    Aabakken, Lars
    Bergestuen, Deidi S.
    Thiis-Evensen, Espen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 734 - 741
  • [23] Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET)
    Andreasi, V.
    Partelli, S.
    Manzoni, M.
    Colombo, B.
    Muffatti, F.
    Corti, A.
    Falconi, M.
    PANCREAS, 2021, 50 (03) : 465 - 466
  • [24] Prognostic Factors for Recurrence of Sporadic Pancreatic Neuroendocrine Tumors after Surgical Resection
    Figueira, E. R. R.
    Bacchella, T.
    Jureidini, R.
    Cunha, J. E. M.
    Namur, G. N.
    Ribeiro, T. C.
    Okubo, J.
    Fernandes, A. G., V
    Cecconello, I
    NEUROENDOCRINOLOGY, 2016, 103 : 97 - 97
  • [25] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    MODERN PATHOLOGY, 2015, 28 : 449A - 449A
  • [26] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    LABORATORY INVESTIGATION, 2015, 95 : 449A - 449A
  • [27] Prognostic biomarkers in pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    VandenBussche, Christopher J.
    CANCER CYTOPATHOLOGY, 2021, 129 (11) : 841 - 843
  • [28] Pattern of Disease Recurrence and Treatment After Surgery for Nonfunctioning Well-Differentiated Pancreatic Neuroendocrine Tumors (NF-PanNET)
    Andreasi, V.
    Partelli, S.
    Landoni, L.
    Nessi, C.
    Muffatti, F.
    Crippa, S.
    Cingarlini, S.
    Bassi, C.
    Falconi, M.
    PANCREAS, 2021, 50 (03) : 459 - 459
  • [29] Genomic and Transcriptomic Characterization of Aggressive Well Differentiated Pancreatic Neuroendocrine Tumors (WD PanNET)
    Cros, J.
    Soukeur, M.
    Raffenne, J.
    Bernard, V
    Scoazec, J. Y.
    Svrcek, M.
    de Mestier, L.
    Hentic, O.
    Hentic, O.
    Bieche, I
    Ruszniewski, P.
    Couvelard, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 26 - 26
  • [30] Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors
    Safatle-Ribeiro, Adriana V.
    Ribeiro, Ulysses, Jr.
    Corbett, Carlos E. P.
    Iriya, Kiyoshi
    Kobata, Cristina H. P.
    Sakai, Paulo
    Yagi, Osmar K.
    Pinto, Paulo E., Jr.
    Zilberstein, Bruno
    Gama-Rodrigues, Joaquim
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (01) : 21 - 28